Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Pending authorization of the Omicron KP.2-adapted vaccine by the EC, both the Omicron KP.2-adapted vaccine and the Omicron JN.1-adapted vaccine will be available across the EU, though availability ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...

Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, ...

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that results from the pivotal Phase 2 AGAVE-201 trial of Niktimvo(axatilimab-csfr), an anti-CSF-1R antibody, in adult and pediatric patients ...

DNA (pDNA) purification system. PlasmidPro enables innovation at scale, providing complete automation across mini and maxi ...

Keith Speights has positions in Pfizer and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Merck, Pfizer, and Vertex Pharmaceuticals. The Motley Fool recommends Moderna. The ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

Moderna, Inc. (NASDAQ:MRNA) shares are moving higher on Tuesday after the company announced that Health Canada approved its ...